
Mina Haghighatian
Examiner (ID: 9203)
| Most Active Art Unit | 1616 |
| Art Unit(s) | 1619, 1616 |
| Total Applications | 1586 |
| Issued Applications | 758 |
| Pending Applications | 194 |
| Abandoned Applications | 669 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17139308
[patent_doc_number] => 20210307319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => Herbicide Compositions With Improved Properties
[patent_app_type] => utility
[patent_app_number] => 17/264205
[patent_app_country] => US
[patent_app_date] => 2019-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8320
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17264205
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/264205 | Herbicide compositions with improved properties | Jul 22, 2019 | Issued |
Array
(
[id] => 17272779
[patent_doc_number] => 20210378977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => Dry Powder Formulations for Messenger RNA
[patent_app_type] => utility
[patent_app_number] => 17/262421
[patent_app_country] => US
[patent_app_date] => 2019-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27123
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -71
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17262421
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/262421 | Dry Powder Formulations for Messenger RNA | Jul 22, 2019 | Pending |
Array
(
[id] => 15083253
[patent_doc_number] => 20190336437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => Drug Condensation Aerosols And Kits
[patent_app_type] => utility
[patent_app_number] => 16/510846
[patent_app_country] => US
[patent_app_date] => 2019-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58679
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16510846
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/510846 | Drug Condensation Aerosols And Kits | Jul 11, 2019 | Abandoned |
Array
(
[id] => 15035581
[patent_doc_number] => 20190328795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => METHODS AND MATERIALS FOR TREATING LUNG DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/505133
[patent_app_country] => US
[patent_app_date] => 2019-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5627
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16505133
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/505133 | Methods and materials for treating lung disorders | Jul 7, 2019 | Issued |
Array
(
[id] => 15631807
[patent_doc_number] => 10588871
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-03-17
[patent_title] => Transdermal formulation for the treatment of pain and/or inflammation
[patent_app_type] => utility
[patent_app_number] => 16/457746
[patent_app_country] => US
[patent_app_date] => 2019-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10325
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 268
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16457746
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/457746 | Transdermal formulation for the treatment of pain and/or inflammation | Jun 27, 2019 | Issued |
Array
(
[id] => 16695440
[patent_doc_number] => 10946009
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-16
[patent_title] => Combination dosage form of a mu opioid receptor antagonist and an opioid agent
[patent_app_type] => utility
[patent_app_number] => 16/454353
[patent_app_country] => US
[patent_app_date] => 2019-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 8323
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16454353
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/454353 | Combination dosage form of a mu opioid receptor antagonist and an opioid agent | Jun 26, 2019 | Issued |
Array
(
[id] => 17064977
[patent_doc_number] => 20210267192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => COMPOSITION AND METHOD FOR REDUCING SPRAY DRIFT
[patent_app_type] => utility
[patent_app_number] => 17/254209
[patent_app_country] => US
[patent_app_date] => 2019-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12921
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17254209
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/254209 | COMPOSITION AND METHOD FOR REDUCING SPRAY DRIFT | Jun 18, 2019 | Abandoned |
Array
(
[id] => 15020571
[patent_doc_number] => 20190321290
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-24
[patent_title] => COMPOSITION AND METHOD FOR INHALATION
[patent_app_type] => utility
[patent_app_number] => 16/434938
[patent_app_country] => US
[patent_app_date] => 2019-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9071
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16434938
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/434938 | COMPOSITION AND METHOD FOR INHALATION | Jun 6, 2019 | Pending |
Array
(
[id] => 14864639
[patent_doc_number] => 20190282561
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => Combinations of Glycopyrrolate and Beta2 Adrenoceptor Agonists
[patent_app_type] => utility
[patent_app_number] => 16/429382
[patent_app_country] => US
[patent_app_date] => 2019-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7747
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16429382
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/429382 | Combinations of Glycopyrrolate and Beta2 Adrenoceptor Agonists | Jun 2, 2019 | Abandoned |
Array
(
[id] => 16868337
[patent_doc_number] => 20210161804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => FLUTICASONE AND VILANTEROL FORMULATION AND INHALER
[patent_app_type] => utility
[patent_app_number] => 17/059614
[patent_app_country] => US
[patent_app_date] => 2019-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10108
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17059614
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/059614 | FLUTICASONE AND VILANTEROL FORMULATION AND INHALER | May 30, 2019 | Abandoned |
Array
(
[id] => 16961456
[patent_doc_number] => 20210212955
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => NANOPARTICLE FOR PROTEIN DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/058925
[patent_app_country] => US
[patent_app_date] => 2019-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24607
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17058925
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/058925 | Nanoparticle for protein delivery | May 27, 2019 | Issued |
Array
(
[id] => 16930858
[patent_doc_number] => 20210196747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => METABOLISM IMPROVING AGENT
[patent_app_type] => utility
[patent_app_number] => 17/057348
[patent_app_country] => US
[patent_app_date] => 2019-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7773
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17057348
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/057348 | METABOLISM IMPROVING AGENT | May 23, 2019 | Pending |
Array
(
[id] => 15586141
[patent_doc_number] => 20200069605
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => CANNABINOID AND MENTHOL COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 16/419336
[patent_app_country] => US
[patent_app_date] => 2019-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10849
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16419336
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/419336 | Cannabinoid and menthol compositions and methods | May 21, 2019 | Issued |
Array
(
[id] => 14833271
[patent_doc_number] => 20190275036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => Intranasal DHE for the Treatment of Headache
[patent_app_type] => utility
[patent_app_number] => 16/414350
[patent_app_country] => US
[patent_app_date] => 2019-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24162
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16414350
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/414350 | Intranasal DHE for the Treatment of Headache | May 15, 2019 | Abandoned |
Array
(
[id] => 15206187
[patent_doc_number] => 20190365780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/412360
[patent_app_country] => US
[patent_app_date] => 2019-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24835
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 215
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16412360
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/412360 | High-strength testosterone undecanoate compositions | May 13, 2019 | Issued |
Array
(
[id] => 14775319
[patent_doc_number] => 20190262557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-29
[patent_title] => DRY POWDER DRUG DELIVERY SYSTEM
[patent_app_type] => utility
[patent_app_number] => 16/410191
[patent_app_country] => US
[patent_app_date] => 2019-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26656
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16410191
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/410191 | DRY POWDER DRUG DELIVERY SYSTEM | May 12, 2019 | Abandoned |
Array
(
[id] => 17020160
[patent_doc_number] => 20210244031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => MUTANTS OF PAENIBACILLUS AND METHODS FOR THEIR USE
[patent_app_type] => utility
[patent_app_number] => 17/054951
[patent_app_country] => US
[patent_app_date] => 2019-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17875
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17054951
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/054951 | Mutants of paenibacillus and methods for their use | May 7, 2019 | Issued |
Array
(
[id] => 14743621
[patent_doc_number] => 20190254984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => COMPOSITION AND FOOD OR DRINK
[patent_app_type] => utility
[patent_app_number] => 16/398529
[patent_app_country] => US
[patent_app_date] => 2019-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10991
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16398529
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/398529 | COMPOSITION AND FOOD OR DRINK | Apr 29, 2019 | Abandoned |
Array
(
[id] => 17226333
[patent_doc_number] => 20210352889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => MACROCYCLIC TETRAPYRROLE COMPOUNDS, COMPOSITIONS AND METHODS FOR INCREASING ABIOTIC STRESS RESISTANCE IN PLANTS
[patent_app_type] => utility
[patent_app_number] => 17/051666
[patent_app_country] => US
[patent_app_date] => 2019-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20980
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17051666
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/051666 | MACROCYCLIC TETRAPYRROLE COMPOUNDS, COMPOSITIONS AND METHODS FOR INCREASING ABIOTIC STRESS RESISTANCE IN PLANTS | Apr 28, 2019 | Pending |
Array
(
[id] => 17226333
[patent_doc_number] => 20210352889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => MACROCYCLIC TETRAPYRROLE COMPOUNDS, COMPOSITIONS AND METHODS FOR INCREASING ABIOTIC STRESS RESISTANCE IN PLANTS
[patent_app_type] => utility
[patent_app_number] => 17/051666
[patent_app_country] => US
[patent_app_date] => 2019-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20980
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17051666
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/051666 | MACROCYCLIC TETRAPYRROLE COMPOUNDS, COMPOSITIONS AND METHODS FOR INCREASING ABIOTIC STRESS RESISTANCE IN PLANTS | Apr 28, 2019 | Pending |